UZH-Logo

Maintenance Infos

Browse by Creators - Zurich Open Repository and Archive

Navigate back| Up a level
Export as
Number of items: 21.

Wenger, R H; Katschinski, D M (2016). The Three "Musketairs" – Lasker Prize 2016 goes to the protagonists of hypoxia research. Hypoxia, 2016(4):101-162.

Wottawa, M; Leisering, P; von Ahlen, Melanie; Schnelle, M; Vogel, S; Malz, C; Bordoli, R M; Camenisch, G; Hesse, A; Napp, J; Alves Cardoso, F; Kristiansen, G; Farhat, K; Katschinski, D M (2013). Knockdown of prolyl-4-hydroxylase domain 2 inhibits tumor growth of human breast cancer MDA-MB-231 cells by affecting TGF-b1 processing. International Journal of Cancer, 132(12):2787-2798.

Wenger, R H; Camenisch, G; Stiehl, D P; Katschinski, D M (2009). HIF Prolyl-4-hydroxylase Interacting Proteins: Consequences for Drug Targeting. Current Pharmaceutical Design, 15(33):3886-3894.

Wirthner, R; Balamurugan, K; Stiehl, D P; Barth, S; Spielmann, P; Oehme, F; Flamme, I; Katschinski, D M; Wenger, R H; Camenisch, G (2007). Determination and modulation of prolyl-4-hydroxylase domain oxygen sensor activity. Methods in Enzymology, 435:43-60.

Ameri, K; Hammond, E M; Culmsee, C; Raida, M; Katschinski, D M; Wenger, R H; Wagner, E; Davis, R J; Hai, T; Denko, N; Harris, A L (2007). Induction of activating transcription factor 3 by anoxia is independent of p53 and the hypoxic HIF signalling pathway. Oncogene, 26(2):284-289.

Eckhardt, K; Troger, J; Reissmann, J; Katschinski, D M; Wagner, K F; Stengel, P J; Paasch, U; Hunziker, P; Borter, E; Barth, S; Schlafli, P; Spielmann, P; Stiehl, D P; Camenisch, G; Wenger, R H (2007). Male germ cell expression of the PAS domain kinase PASKIN and its novel target eukaryotic translation elongation factor eEF1A1. Cellular Physiology and Biochemistry, 20(1-4):227-240.

Köditz, J; Nesper, J; Wottawa, M; Stiehl, D P; Camenisch, G; Franke, C; Myllyharju, J; Wenger, R H; Katschinski, D M (2007). Oxygen-dependent ATF-4 stability is mediated by the PHD3 oxygen sensor. Blood, 110(10):3610-3617.

Barth, S; Nesper, J; Hasgall, P A; Wirthner, R; Nytko, K J; Edlich, F; Katschinski, D M; Stiehl, D P; Wenger, R H; Camenisch, G (2007). The peptidyl prolyl cis/trans isomerase FKBP38 determines hypoxia-inducible transcription factor prolyl-4-hydroxylase PHD2 protein stability. Molecular and Cellular Biology, 27(10):3758-3768.

Hägele, S; Behnam, B; Borter, E; Wolfe, J; Paasch, U; Lukashev, D; Sitkovsky, M; Wenger, R H; Katschinski, D M (2006). TSGA10 prevents nuclear localization of the hypoxia-inducible factor (HIF)-1alpha. FEBS Letters, 580(15):3731-3738.

Martin, F; Linden, T; Katschinski, D M; Oehme, F; Flamme, I; Mukhopadhyay, C K; Eckhardt, K; Tröger, J; Barth, S; Camenisch, G; Wenger, R H (2005). Copper-dependent activation of hypoxia-inducible factor (HIF)-1: implications for ceruloplasmin regulation. Blood, 105(12):4613-4619.

Ibrahim, N O; Hahn, T; Franke, C; Stiehl, D P; Wirthner, R; Wenger, R H; Katschinski, D M (2005). Induction of the hypoxia-inducible factor system by low levels of heat shock protein 90 inhibitors. Cancer Research, 65(23):11094-11100.

Wenger, R H; Katschinski, D M (2005). The hypoxic testis and post-meiotic expression of PAS domain proteins. Seminars in Cell and Developmental Biology, 16(4-5):547-553.

Depping, R H; Hägele, S; Wagner, K F; Wiesner, R J; Camenisch, G; Wenger, R H; Katschinski, D M (2004). A dominant-negative isoform of hypoxia-inducible factor-1 alpha specifically expressed in human testis. Biology of Reproduction, 71(1):331-339.

Katschinski, D M; Le, L; Schindler, S G; Thomas, T; Voss, A K; Wenger, R H (2004). Interaction of the PAS B domain with HSP90 accelerates hypoxia-inducible factor-1alpha stabilization. Cellular Physiology and Biochemistry, 14(4-6):351-360.

Shibata, J H W; Hasegawa, J; Siemens, H J; Wolber, E; Dibbelt, L; Li, D; Katschinski, D M; Fandrey, J; Jelkmann, W; Gassmann, M; Wenger, R H; Wagner, K F (2003). Hemostasis and coagulation at a hematocrit level of 0.85: functional consequences of erythrocytosis. Blood, 101(11):4416-4422.

Katschinski, D M; Marti, H H; Wagner, K F; Shibata, J; Eckhardt, K; Martin, F; Depping, R; Paasch, U; Gassmann, M; Ledermann, B; Desbaillets, I; Wenger, R H (2003). Targeted disruption of the mouse PAS domain serine/threonine kinase PASKIN. Molecular and Cellular Biology, 23(19):6780-6789.

Linden, T; Katschinski, D M; Eckhardt, K; Scheid, A; Pagel, H; Wenger, R H (2003). The antimycotic ciclopirox olamine induces HIF-1alpha stability, VEGF expression, and angiogenesis. FASEB Journal, 17(6):761-763.

Unruh, A; Ressel, A; Mohamed, H G; Johnson, R S; Nadrowitz, R; Richter, E; Katschinski, D M; Wenger, R H (2003). The hypoxia-inducible factor-1 alpha is a negative factor for tumor therapy. Oncogene, 22(21):3213-3220.

Katschinski, D M; Le, L; Heinrich, D; Wagner, K F; Hofer, T; Schindler, S G; Wenger, R H (2002). Heat induction of the unphosphorylated form of hypoxia-inducible factor-1alpha is dependent on heat shock protein-90 activity. Journal of Biological Chemistry, 277(11):9262-9267.

Marti, H H; Katschinski, D M; Wagner, K F; Schäffer, L; Stier, B; Wenger, R H (2002). Isoform-specific expression of hypoxia-inducible factor-1alpha during the late stages of mouse spermiogenesis. Molecular Endocrinology, 16(2):234-243.

Hofer, T; Spielmann, P; Stengel, P; Stier, B; Katschinski, D M; Desbaillets, I; Gassmann, M; Wenger, R H (2001). Mammalian PASKIN, a PAS-serine/threonine kinase related to bacterial oxygen sensors. Biochemical and Biophysical Research Communications (BBRC), 288(4):757-764.

This list was generated on Sat Jul 22 19:05:30 2017 CEST.